Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Regional Citrate Anticoagulation (RCA): later-stage trial registry

1 of 1 indexed Regional Citrate Anticoagulation (RCA) trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Regional Citrate Anticoagulation (RCA): 1 US clinical trial tracked, 1 recruiting.

Regional Citrate Anticoagulation (RCA) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Vantive Health, running 1 of these trials.

Enrollment posture brief

Registry condition regional-citrate-anticoagulation-rca

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Regional Citrate Anticoa (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Regional Citrate Anticoagulation (RCA)

Regional Citrate Anticoagulation (RCA) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Regional Citrate Anticoagulation (RCA) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Regional Citrate Anticoagulation (RCA) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Vantive Health 1 trials

Named interventions

Most-linked intervention names on Regional Citrate Anticoagulation (RCA) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

PrisMax System Version 3.x with calcium line accessory Device
1 trials
Prismocitrate 18 Drug
1 trials

US sites by state

Facility locations filed on Regional Citrate Anticoagulation (RCA) trials. A trial with sites in several states counts in each.

Texas 1 trials
Tennessee 1 trials
South Carolina 1 trials
Pennsylvania 1 trials
Ohio 1 trials
Michigan 1 trials
Georgia 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Regional Citrate Anticoagulation (RCA) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Regional Citrate Anticoagulation (RCA) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Vantive Health sponsors the most Regional Citrate Anticoagulation (RCA) trials on record, review their full trial history before evaluating a specific study. See Vantive Health's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Regional Citrate Anticoagulation (RCA) condition card totals 1 registered trials; most-linked intervention PrisMax System Version 3.x with calcium line accessory; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.